Etintidine

依汀替丁

Report date: 2023/04/21 17:47:01
NME

Base Information

Drug NameEtintidine
Drug Alias NameBL-5641
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H2 receptor antagonists
TargetsHistamine H2 receptor
Therapy Area/IndicationsPeptic Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsPeptic Ulcer

Other Information

ATC CodeN/A
Related LinksKEGG